eliprodil has been researched along with Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapin, MA; Opitz, T; Reyes, A; Reyes, M; Stanton, PK | 1 |
| Chandler, ML; DeSantis, LM; Doshi, R; Kapin, MA; Scatton, B | 1 |
2 other study(ies) available for eliprodil and Ischemia
| Article | Year |
|---|---|
Eliprodil, a non-competitive, NR2B-selective NMDA antagonist, protects pyramidal neurons in hippocampal slices from hypoxic/ischemic damage.
Topics: Animals; Excitatory Amino Acid Antagonists; Hippocampus; Hypoxia; In Vitro Techniques; Ischemia; Male; N-Methylaspartate; Neuroprotective Agents; Piperidines; Pyramidal Cells; Rats; Rats, Sprague-Dawley | 1998 |
Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia.
Topics: Animals; Choline O-Acetyltransferase; Electroretinography; Injections; Injections, Intraperitoneal; Ischemia; N-Methylaspartate; Neuroprotective Agents; Neurotoxins; Piperidines; Rats; Rats, Long-Evans; Retina; Retinal Ganglion Cells; Retinal Vessels; Vitreous Body | 1999 |